Quantum Innovations raises nearly €10 million for industry-first surgical sensor technology

Polish medical technology company Quantum Innovations has raised almost €10 million in its second funding round.

The team led by Grzegorz Suwalski, MD, PhD, developed the world's first sensor technology to monitor organs during surgery and transplantation.

The development of medical technologies significantly increases the success rate of cardiothoracic surgeries while reducing complications and mortality rates. Surgical procedures, especially those involving internal organs, require extreme precision and continuous monitoring. None of the tools or equipment currently available offer such capabilities.

Quantum Innovations aims to fill this gap.

Their Heart Sense solution enables real-time ECG monitoring directly from the surface of a beating heart.

Additionally, Heart Guard technology tracks tissue metabolism, including during periods when the heart is stopped for cardiac surgery.

According to Grzegorz Suwalski, founder and CEO of Quantum Innovations:

“Heart Sense technology makes it possible to examine the ECG of the operated heart, in any of its positions, from any of its walls, directly from its surface.

Heart Guard technology, for its part, monitors heart acidification based on metabolism. Studies indicate that using this data can help cardiac teams overcome knowledge gaps and prevent dangerous complications and deaths in patients. »

Vinci IQ ASI, a fund created by BGK and managed by Vinci SA, led the financing, with participation from the company's existing investor, MedTech Holding.

According to Piotr Woliński, president of Vinci SA:

“We were convinced to invest primarily by the revolutionary product and technology, as well as the team's practical experience.

The solutions offered by QI meet an unmet need in clinical practice during cardiothoracic surgeries. The introduction of these solutions into medical standards has the potential to significantly reduce complications and perioperative mortality associated with cardiac surgeries.

The fundraising currently raised by the Quantum Innovations team will be used to develop and set up a clean room production line. It will also carry out the necessary certifications, including regulatory and human clinical trials, which will help commercialize the product in global markets.

Main image: Quantum innovations. Photo: uncredited.